Skip to main content
All lobbying filings

LMH STRATEGIC SOLUTIONS

Lobbying for MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Trade association for medical device manufacturers.

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $20,000.00 income · posted Apr 17, 2026

Official filing document

 Bills named in this filing 1
  • HR 1691
    Ensuring Patient Access to Critical Breakthrough Products Act of 2024
 Lobbying activity 2
Medicare/Medicaid

Access to and reimbursement of medical devices in Medicare program. Issues related to Medicare coverage reform. Issues related to Medicare coverage for digital health technologies. Issues related to capping beneficiary copayments for Medicare beneficiaries in ambulatory surgery centers. Issues related to CMS expansion of prior authorization requirements for medical procedures.

Health Issues

Health programs impacting MDMA. Issues related to medical devices. Issues related to FDA approval of medical devices. Issues related to sterilization of medical devices. Barriers to market access for medical device companies. Issues related to the coverage for FDA Breakthrough products and the H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act. Issues related to Medical Device User Fee Amendments (MDUFA) implementation. Issues related to physician fee schedule. Issues related to coverage of telehealth services. Issues related to regulation and reimbursement of artificial intelligence in healthcare. Issues related to Transitional Coverage for Emerging Technologies (TCET)(CMS-3421-NC). Supply chain issues. Cyber security issues related to consumer and health data privacy. TCET Issues related to the New Technology Add on Payment (NTAP).

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem